Sleep drug may curb opioid cravings in early trial
NCT ID NCT05829655
First seen Jan 07, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study tests whether suvorexant, a sleep aid, can lower the desire for drugs in people with opioid use disorder. Researchers will measure how much drug participants choose at different prices. The trial is in early stages and is currently on hold.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
General Clinical Research Center
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.